| Financial Year |
March 31 2023 |
| Monetary Funds |
249,224,607.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
2,623,495.54 |
| Advances to Suppliers |
-- |
| Other Receivables |
1,132,353.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
409,224.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
437,521.02 |
| Total Current Assets |
254,197,114.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,057,172.59 |
| Investment Properties |
-- |
| Fixed Assetes |
412,120,616.19 |
| Under-construction Projects |
7,555,214.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
202,373,822.38 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
1,000,000.00 |
| Sub-Total of Non-Current Assets |
628,106,825.31 |
| Total Assets |
882,303,939.65 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
9,767,017.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,144,532.92 |
| Taxes Payable |
563,478.84 |
| Interest Payable |
-- |
| Dividend Payable |
1,260,472.60 |
| Other payables |
418,539,533.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
533,243,259.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,701,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,701,000.00 |
| Total Liabilities |
534,944,259.92 |
| Paid-In Capital(Or Share Stock) |
62,458,000.00 |
| Capital Surplus |
145,663,447.66 |
| Surplus Reserve |
7,344,613.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
25,597,120.73 |
| Minority Stockholder's Interest |
106,296,497.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
241,063,181.84 |
| Owner's Equity（Stockholder's Equity） |
347,359,679.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
882,303,939.65 |
